A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device
SB Technology, Inc.
Summary
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction * Ability for participant to comply with study requirements * Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities * Written informed consent Exclusion Criteria: * Present STEMI * Pregnant or breastfeeding * Having an active atrial fibrillation episode as seen on most current 12-lead ECG * Active thoracic metal implant * Poor access to…
Interventions
- DeviceSponsor MCG device (CardiAQ)
Unshielded magnetocardiography device for measuring cardiac magnetic fields
Locations (2)
- Mayo ClinicRochester, Minnesota
- Mount Sinai HospitalNew York, New York